Biostar Pharmaceuticals, Inc. BSPM +5.94%("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its Chairman and Chief Executive Officer, Mr. Ronghua Wang, will attend the Asia-Pacific Economic Cooperation (APEC) 2011 CEO Summit, which will take place from November 11 - 12, 2011 in Honolulu, Hawaii.Additionally, on November 10, 2011, Mr. Wang will present at the Asia-Pacific Business Symposium, a two-day series of workshops, held in conjunction with APEC 2011 CEO Summit. During his speech, Mr. Wang will focus on the importance of the cooperation between United States and China on trade and investment and discuss his experience as a CEO of a U.S. listed company.The Asia-Pacific Business Symposium is sponsored by the Pacific Basin Economic Council, the East-West Center and supported by the APEC Business Advisory Council. The Symposium will be a gathering of business leaders from around the Asia-Pacific Region, including many attendees of APEC 2011 CEO Summit, to discuss various topics related to trade, sustainability, and other issues of importance to the region.The APEC CEO Summit is the Asia-Pacific's premier business event, drawing thousands of economic and business leaders from around the region and beyond. The APEC CEO Summit provides unparalleled opportunity for business executives to dialogue with global leaders and ministers of foreign affairs and trade, network with CEOs from hundreds of top Asia-Pacific companies, and to forge connections with economic thought leaders from around the region and the world. Barack Obama, President of the United States, along with Hu Jintao, President of China, Dmitry Medvedev, President of Russia, and Susilo Bambang Yudhoyono, President of Indonesia, are among world leaders expected at the APEC CEO 2011 Summit.Mr. Wang commented, "I am honored to again be invited to be part of the Chinese delegation and represent our nation's pharmaceutical industry in both these important economic events. On November 12th, at the APEC CEO 2011 Summit, the Chinese delegation headed by President Hu Jintao will discuss health trends in Asia, the region's aging population and how changes in diet and exercise have resulted in an increase in chronic diseases in Asian economies, posing a rising burden on business and society. I look forward to discussing these issues with world and business leaders and sharing ideas and possible solutions that could reverse these trends, and exploring policy choices weighing both opportunities and obstacles that lie ahead of us."
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment